Ticker
XGNCompany Name
EXAGEN INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQDate | Shareholders Equity | Net Income Common Stock | Return on Equity |
---|---|---|---|
6/30/2025 | $ 21.03M | $ -16.98M | -80.73% |
3/31/2025 | $ 6.4M | $ -15.51M | -242.18% |
12/31/2024 | $ 9.54M | $ -15.12M | -158.44% |
9/30/2024 | $ 12.87M | $ -16.93M | -131.54% |
6/30/2024 | $ 17.59M | $ -17.31M | -98.46% |
3/31/2024 | $ 19.99M | $ -19.36M | -96.85% |
12/31/2023 | $ 22.69M | $ -23.69M | -104.38% |
9/30/2023 | $ 27.5M | $ -32.47M | -118.06% |
6/30/2023 | $ 31.9M | $ -35.15M | -110.18% |
3/31/2023 | $ 35.94M | $ -44.8M | -124.67% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Equity
(=) ROE
ROE for EXAGEN INC is calculated as follows: Net Inc. Cmn. [ $ -16.64M ] / Equity [ $ 44.47M ]
(=) ROE [ -37.42% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.14K |
---|---|
min | -66.79% |
max | 73.25% |
average | 1.51% |
median | 6.45% |
std | 22.68% |